Market Place
Sourcing Support
All News #Library
Biotech
Immune-Onc Doses 1st Patient In IO-108 Ph 1b/2 Liver Study With Roche
27 Feb 2025 //
BUSINESSWIRE
Immune-Onc Presents Promising IO-202 Data in CMML Patients at ASH
09 Dec 2024 //
BUSINESSWIRE
Immune-Onc Presents IO-202 CMML Data At EHA 2024 Congress
14 May 2024 //
BUSINESSWIRE
Immune-Onc Presents IO-202 PhI Data in Patients with Relapsed or Refractory AML
07 Jun 2023 //
BUSINESSWIRE
Immune-Onc to Present Encouraging Phase 1 Data for IO-108 at AACR Meeting 2023
14 Apr 2023 //
BUSINESSWIRE
Immune-Onc Announces IO-108 Phase I Trial Results Selected for Presentation
14 Mar 2023 //
BUSINESSWIRE
Immune-Onc Therapeutics Announces Close of Series B Extension Financing
05 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.